Sarah Cannon Research Institute and Tennessee Oncology — Nashville, Tennessee

Sarah Cannon Research Institute and Tennessee Oncology is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Health Trust Score: 48/100 (POOR). This profile has not yet been claimed by the site owner.

Sarah Cannon Research Institute and Tennessee Oncology has participated in 1 clinical trials.

Therapeutic areas: Triple Negative Breast Cancer, TNBC - Triple-Negative Breast Cancer, Non-small Cell Lung Cancer.

Sponsors: Lyell Immunopharma, Inc..

Sponsor Feasibility Report

Trust Score: 48/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Sarah Cannon Research Institute and Tennessee Oncology?

Sarah Cannon Research Institute and Tennessee Oncology has a Crixeo Trust Score of 48/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Sarah Cannon Research Institute and Tennessee Oncology conducted?

Sarah Cannon Research Institute and Tennessee Oncology has 1 clinical trials on record. Their work covers Triple Negative Breast Cancer, TNBC - Triple-Negative Breast Cancer, Non-small Cell Lung Cancer.

Is Sarah Cannon Research Institute and Tennessee Oncology accredited by Crixeo Health?

Sarah Cannon Research Institute and Tennessee Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Sarah Cannon Research Institute and Tennessee Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.